English

More about this topic

Healthcare

Italy unveils plans for €4.2 million fund to target obesity

The creation of the fund is viewed as a small but meaningful step to address Italy’s looming obesity problem but critics remain unconvinced of its impact.

Health news

England to roll out new anti-obesity drug but only for some patients

The drug is expected to cost €381.1 million per year within three years.

Business

Eli Lilly shares rise as Zepbound weight-loss test shows solid success

Lilly said patients taking Zepbound lost about 20% of their weight on average compared with nearly 14% for Wegovy. The drug maker also said more patients taking Zepbound achieved at least 25% weight loss.

Health news

Weight loss drugs could help fight chronic kidney disease, study finds

Researchers said the drugs could make a major difference for chronic kidney disease patients by helping to reduce other risk factors.

ADVERTISEMENT

Europe News

Why has the EU deforestation law become so politicised?

Germany's national elections are influencing the negotiations of EU deforestation law, which entered interinstitutional negotiations on 21 November, according to campaigner.

Health news

Weight loss yo-yo effect linked to fat cell ‘memory,’ study finds

Fat cells were found to retain a long-lasting "memory" of obesity making it hard to maintain weight loss results.

Health news

Weight-loss drugs like Ozempic may reduce opioid overdose rates

A new study found a link between new popular GIP/GLP-1 receptor agonists and a reduced rate of overdose or intoxication in people with opioid and alcohol use disorders.

Health news

Teens on anti-obesity drugs less likely to consider or attempt suicide

Researchers said the drugs don’t appear to raise the risk of suicidal thoughts or actions for young people but also urged caution in interpreting the results.

Health news

France to patients: Take weight loss drug Wegovy on your own dime

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.

Business

Novo Nordisk boss in US grilling over prices for weight-loss drugs

Novo Nordisk has been criticised by US politicians for the high pricing of its popular weight-loss and diabetes drugs. But CEO Lars Fruergaard Jørgensen has defended the company, attributing the elevated prices to "structural issues" within the US healthcare system.

Health news

Severe obesity is rising in the US, according to new research

The rate of severe obesity is about 40 per cent in the US, with women at particularly high risk of severe obesity, the study found.

Business

Weight loss market: Eli Lilly and Novo Nordisk's rivals muscle in

As Eli Lilly and Novo Nordisk continue to dominate the lucrative weight-loss drug market, smaller competitors are gearing up to release their own treatments, aiming to challenge the two industry leaders.

Health news

Women on weight loss drug lose more weight than men, study finds

A new study found that women using the weight loss drug tirzepatide (Mounjaro) lost more weight than men, but experienced higher rates of side effects like nausea and vomiting.

Health news

Weight-loss drug 'safe and effective' for kids as young as 6

Novo Nordisk asked US regulators to approve the drug for children ages 6 to 11. In the EU, it's available for adolescents as young as 12.

Business

Investors look to weight loss drugs to boost Novo Nordisk growth

Novo Nordisk is releasing its second-quarter earnings on Wednesday, with analysts expecting more than 20% growth driven by Ozempic and Wegovy sales. However, the company faces challenges from more competition.

Health news

New study sheds light on illegal online pharmacies selling semaglutide

Researchers looked at the composition of online purchases of semaglutide, the popular drug usually prescribed for diabetes or obesity.

Health news

Weight loss drug may cut heart failure risk, company says

New results from a clinical trial evaluating the drug showed positive results for reducing heart failure risk.

Health news

Weight-loss jabs may help patients stop smoking but trials needed

A new study looked at the influence of popular weight-loss drugs on medical care related to tobacco use.

Business

Roche plans speedy weight-loss drug launch to catch up with rivals

Roche believes its anti-obesity drugs could have advantages over other more established rivals such as Eli Lilly and Novo Nordisk through ease of scalability that will allow it to meet increased demand.

Lifestyle

Hundreds of Italian residents join their mayor on weight loss walks

A small Italian town mayor's fight to loss weight has gone viral after he campaigned for company on his weekly walks.